Chen Lifang, Xu Jianing, Sun Hao, Wu Hao, Zhang Jinsong
Department of Emergency, The first affiliated hospital with Nanjing Medical University, Nanjing, Jiangsu, China.
J Clin Lab Anal. 2017 Nov;31(6). doi: 10.1002/jcla.22139. Epub 2017 Jan 26.
High admission cholesterol has been associated with better outcome after acute ischaemic stroke (AIS), but a paradox not completely illustrated. The purpose of this study was to investigate the effect of the total cholesterol to high-density lipoprotein cholesterol (TC/HDL-C) on short-term survival after AIS.
Consecutive patients admitted in 2013 and 2015 were enrolled in the present study. The logistic regression analysis was conducted to evaluate predictors of 3-month outcomes. The primary endpoint was death. Secondary endpoint was good (modified Rankin Scale score 0-2 or equal to prestrike modified Rankin Scale score) at 3 months.
Of 871 patients enrolled in the final analysis, 94 (10.8%) individuals died during 3 months of observation. The serum TC and TC/HDL-C levels at admission were significantly associated with stroke outcomes at 3 months, and the HDL-C level was only correlated with the good outcomes at 3 months. Mortality risk was markedly decreased for patients with high TC/HDL-C ratio (odds ratio: 0.23, 95% confidence interval [CI]: 0.10-0.50 for Q4:Q1; P-trend <.001) after adjustment. The effect of TC/HDL-C ratio on the probability of good outcomes was still obvious (odds ratio: 2.18, 95% CI: 1.40-3.39 for Q4:Q1; P-trend=.029). According to the receiver operating characteristic analyses, the best discriminating factor was a TG/HDL-C ≥3.37 (area under the ROC curve [AUC]=0.643, sensitivity 61.3%, specificity 61.7%) as well as the TC/HDL-C ≥4.09 for good outcomes (AUC: 0.587, sensitivity 63.9%, specificity 79.7%).
High TC/HDL-C ratio may be associated with increased short-term survival and better outcomes after AIS.
急性缺血性卒中(AIS)后,入院时胆固醇水平较高与较好的预后相关,但这一矛盾现象尚未完全阐明。本研究旨在探讨总胆固醇与高密度脂蛋白胆固醇比值(TC/HDL-C)对AIS后短期生存的影响。
纳入2013年和2015年连续入院的患者。进行逻辑回归分析以评估3个月预后的预测因素。主要终点为死亡。次要终点为3个月时预后良好(改良Rankin量表评分0 - 2或等于卒中前改良Rankin量表评分)。
最终分析纳入的871例患者中,94例(10.8%)在3个月观察期内死亡。入院时血清TC和TC/HDL-C水平与3个月时的卒中预后显著相关,但HDL-C水平仅与3个月时的良好预后相关。调整后,TC/HDL-C比值高的患者死亡风险显著降低(比值比:0.23,第4四分位数与第1四分位数相比的95%置信区间[CI]:0.10 - 0.50;P趋势<.001)。TC/HDL-C比值对良好预后概率的影响仍然明显(比值比:2.18,第4四分位数与第1四分位数相比的95% CI:1.40 - 3.39;P趋势 = 0.029)。根据受试者工作特征分析,最佳鉴别因素是TG/HDL-C≥3.37(ROC曲线下面积[AUC]=0.643,敏感性61.3%,特异性61.7%)以及TC/HDL-C≥4.09用于良好预后(AUC:0.587,敏感性63.9%,特异性79.7%)。
高TC/HDL-C比值可能与AIS后短期生存率增加和更好的预后相关。